Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody).
- 19 February 2004
- journal article
- Published by Wiley in British Journal of Dermatology
- Vol. 150 (2) , 380-382
- https://doi.org/10.1111/j.1365-2133.2003.05760.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Corticosteroid-Resistant Pyoderma gangrenosum Associated with Crohn’s Disease: Rapid Cure with InfliximabDermatology, 2002
- Perspectives for TNF-α-targeting therapiesArthritis Research & Therapy, 2002
- Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosumBritish Journal of Dermatology, 1999
- Efficacy of human intravenous immune globulin in pyoderma gangrenosumJournal of the American Academy of Dermatology, 1995
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- Pyoderma gangrenosum, rheumatoid arthritis, and diabetes mellitusArchives of Dermatology, 1966